Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00054535 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: recombinant fowlpox-tyrosinase vaccine
BIOLOGICAL: vaccinia-tyrosinase vaccine

Sponsor

National Cancer Institute (NCI)